Skip to content

Clinical trials

Musculoskeletal Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20122
20142
20174
20192
20211
20223
20231
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Recruiting3
Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Calcilytix Therapeutics, Inc., a BridgeBio company2
Fulcrum Therapeutics2
Leiden University Medical Center2
Vertex Pharmaceuticals Incorporated2
Amgen1
Amsterdam UMC, location VUmc1
Amsterdam University of Applied Sciences1
AstraZeneca1
Avidity Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases24
Joint Diseases8
Muscular Diseases7
Neuromuscular Diseases7
Muscular Dystrophies6
Arthritis5
Nervous System Diseases5
Arthritis, Rheumatoid4
Genetic Diseases, Inborn4
Muscular Disorders, Atrophic4

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.